Indaptus Therapeutics, Inc. (INDP)

NASDAQ: INDP · Real-Time Price · USD

8.44

+0.20 (2.43%)

Aug 13, 2025, 4:00 PM - Market closed

Indaptus Therapeutics Employees

Indaptus Therapeutics had 7 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

7

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$2,423,062

Market Cap

4.83M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	7	0	-
Dec 31, 2023	7	1	16.67%
Dec 31, 2022	6	1	20.00%
Dec 31, 2021	5	3	150.00%
Dec 31, 2020	2	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

INDP News

1 day ago - Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
6 weeks ago - Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
7 weeks ago - Indaptus Therapeutics Announces Reverse Stock Split - GlobeNewsWire
2 months ago - Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
2 months ago - Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab - GlobeNewsWire
3 months ago - Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
3 months ago - Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit - GlobeNewsWire
5 months ago - Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit - GlobeNewsWire